LFMD News & Events

LifeMD announced the closing of a new senior secured revolving credit facility with Citizens Bank. The facility has a maturity date of January 2, 2029 and provides for up to $50M of total availability consisting of $30M of committed availability with an additional accordion option of up to $20M. As of closing, no balance was drawn on the RCF as the Company believes its cash on hand and expected cash flow are sufficient to fund its organic growth initiatives.

LifeMD (LFMD) announced it is now offering Novo Nordisk's (NVO) Wegovy pill, the first and only FDA-approved oral GLP-1 therapy for chronic weight management and cardiovascular health, through its end-to-end telehealth platform. Eligible patients can access the Wegovy pill for as little as $149 per month, further expanding LifeMD's portfolio of branded obesity treatments, LifeMD said. This announcement broadens LifeMD's long-standing collaboration with Novo Nordisk.